Jet-lag drug could help can­cer pa­tients

The Daily Telegraph - - News -

♦ A drug that re­lieves jet lag could pre­vent one of the most de­bil­i­tat­ing side ef­fects of chemo­ther­apy.

Re­searchers at Ed­in­burgh Uni­ver­sity are start­ing clin­i­cal tri­als of mela­tonin on can­cer pa­tients af­ter ex­per­i­ments showed it sig­nif­i­cantly im­proved chemo­ther­apy-in­duced neu­ro­pathic pain. The side ef­fect, which causes tin­gling pain sen­sa­tions, par­tic­u­larly in the fin­gers, af­fects 70 per cent of pa­tients treated with chemo­ther­apy each year, forc­ing many to aban­don their can­cer treat­ment.

Pro­fes­sor Les­ley Colvin, a pain spe­cial­ist at Ed­in­burgh Uni­ver­sity, said: “This is an area where new ther­a­pies are ur­gently re­quired.”

The find­ings were pub­lished in the Jour­nal of Pineal Re­search.

Newspapers in English

Newspapers from UK

© PressReader. All rights reserved.